Fertility Clinics in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Fertility Clinics Market Research Report | Life Sciences | Blood & Organ Banks | May 2016

Fertile ground: Technological advances have increased industry success rates, boosting demand

The Fertility Clinics market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Genea Genea market share
Monash IVF Group Monash IVF Group market share
Virtus Health Virtus Health market share
Industry Statistics & Market Size
Annual Growth 11-16
Annual Growth 16-21
Purchase to read more
Purchase to read more
Industry Analysis & Industry Trends

One in six Australian couples suffers from infertility. The Fertility Clinics industry assists patients who are unable to conceive naturally. There are a number of treatment options included in the industry, the most popular of which is in-vitro fertilisation (IVF) cycles. Over five years through 2015-16, the number of completed IVF cycles in Australia is expected to grow by an annualised 3.6%, to reach 43,400 cycles. Several factors have led to the increasing demand for infertility treatments and procedures, particularly from women who are choosing to have children later in life. Australia is one of the few developed countries in the world that has substantial government funding for fertility treatments, which has made fertility treatment in Australia more affordable... purchase to read more

Industry Report - Industry Products Chapter

Fertility clinics mainly carry out IVF and fertility services for clients. Core assisted reproductive treatments (ART) include in-vitro fertilisation cycles (IVF cycle), intracytoplasmic sperm injection (ICSI), frozen embryo transfers (FET) and intra-uterine and donor insemination. Medicare funding is available for each of these treatments with most procedures also incurring out-of-pocket or 'gap' expenses. However, in some instances, patients may not be eligible for Medicare rebates with Medicare making a distinction between medical infertility (which is covered) and social infertility (which is not covered). The existence of this distinction can influence the type and number of treatments undertaken by a patient... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Fertility Clinics Industry?

Medical facilities in this industry offer treatments to aid individuals in conceiving children. These facilities offer diagnosis, medications, intrauterine insemination and other Assisted Reproductive Technology (ART) methods. It thus covers core ART treatments such as IVF cycles and frozen embryo transfers as well as associated ancillary health services including specialised diagnostic and genetic testing, ultrasounds and related day hospital procedures.

Industry Products
IVF cyclesFrozen embryo transferOther fertility treatmentsDiagnostic and ancillary servicesICIS
Industry Activities
Intracytoplasmic sperm injectionIntrauterine insemination and donor inseminationIn-vitro fertilisation (IVF) cyclesFrozen embryo transferOther fertility treatmentsSpecialised diagnostic testing including pre-implantation genetic diagnosis Ancillary services including patient procedures in day hospitals

View Sample
Select Clients